Evidence map›Paper›PMID 29766293›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2019

NMDA receptor subunits change in the prefrontal cortex of pure-opioid and multi-drug abusers: a post-mortem study.

Hamidreza Daneshparvar, Mitra-Sadat Sadat-Shirazi, Monir Fekri, Solmaz Khalifeh, Ali Ziaie, Nasrin Esfahanizadeh, Nasim Vousooghi, Mohammad-Reza Zarrindast

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Opioid-Induced Regulation of Cortical Circular-International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Hamidreza DaneshparvarLegal Medicine Research Center, Legal Medicine Organization, Tehran, Iran.
Mitra-Sadat Sadat-ShiraziIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, P.O.Box: 13145-784, Iran.
Monir FekriIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, P.O.Box: 13145-784, Iran.
Solmaz KhalifehCognitive and Neuroscience research Center (CNRC), Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran.
Ali ZiaieLegal Medicine Center, Tehran, Iran.
Nasrin EsfahanizadehDepartment of Periodontics, Tehran Dental Branch, Islamic Azad University, Tehran, Iran.
Nasim VousooghiIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, P.O.Box: 13145-784, Iran.
Mohammad-Reza ZarrindastIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, P.O.Box: 13145-784, Iran. zarinmr@ams.ac.ir.
Tehran University of Medical Sciences · IRIranian Legal Medicine Organization · IRIslamic Azad University Dental Branch of Tehran · IRIslamic Azad University Medical Branch of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Addiction is a chronic relapsing disorder and is one of the most important issues in the world. Changing the level of neurotransmitters and the activities of their receptors, play a major role in the pathophysiology of substance abuse disorders. It is well-established that N-methyl-D-aspartate receptors (NMDARs) play a significant role in the molecular basis of addiction. NMDAR has two obligatory GluN1 and two regionally localized GluN2 subunits. This study investigated changes in the protein level of GluN1, GluN2A, and GluN2B in the prefrontal cortex of drug abusers. The medial prefrontal cortex (mPFC), lateral prefrontal cortex (lPFC), and orbitofrontal cortex (OFC) were dissected from the brain of 101 drug addicts brains and were compared with the brains of non-addicts (N = 13). Western blotting technique was used to show the alteration in NMDAR subunits level. Data obtained using Western blotting technique showed a significant increase in the level of GluN1 and GluN2B, but not in GluN2A subunits in all the three regions (mPFC, lPFC, and OFC) of men whom suffered from addiction as compared to the appropriate controls. These findings showed a novel role for GluN1, GluN2B subunits, rather than the GluN2A subunit of NMDARs, in the pathophysiology of addiction and suggested their role in the drug-induced plasticity of NMDARs.

Indexed as

AdultAutopsyHumansMaleNerve Tissue ProteinsPrefrontal CortexReceptors, N-Methyl-D-AspartateSubstance-Related DisordersGRIN1 protein, humanNerve Tissue ProteinsNR2B NMDA receptorReceptors, N-Methyl-D-AspartateAddictionN-Methyl-D-aspartate (NMDA) receptorOpioidPost-mortemPrefrontal cortex

Identifiers

PMID29766293
OpenAlexW2803803580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.